Pediatric Intensive Care Unit, Department of Pediatrics, Jolimont Hospital, La Louvière, Belgium.
Institut de Pathologie et de Génétique, Gosselies (Charleroi), Belgium.
Mol Genet Genomic Med. 2024 Feb;12(2):e2388. doi: 10.1002/mgg3.2388.
Biallelic pathogenic variants in SLC5A6 resulting in sodium-dependent multivitamin transporter (SMVT) defect have recently been described as a vitamin-responsive inborn error of metabolism mimicking biotinidase deficiency. To our knowledge, only 16 patients have been reported so far with various clinical phenotypes such as neuropathy and other neurologic impairments, gastro-intestinal dysfunction and failure to thrive, osteopenia, immunodeficiency, metabolic acidosis, hypoglycemia, and recently severe cardiac symptoms.
We describe a case report of a 5-month-old girl presenting two recurrent episodes of metabolic decompensation and massive cardiac failure in the course of an infectious disease. We compare clinical, biological, and genetic findings of this patient to previous literature collected from Pubmed database (keywords: Sodium-dependent multivitamin transporter (SMVT), SMVT defect/disorder/deficiency, SLC5A6 gene/mutation).
We highlight the life-threatening presentation of this disease, the stagnation of psychomotor development, the severe and persistent hypogammaglobulinemia, and additionally, the successful clinical response on early vitamin supplementation (biotin 15 mg a day and pantothenic acid 100 mg a day). Metabolic assessment showed a persistent increase of urinary 3-hydroxyisovaleric acid (3-HIA) as previously reported in this disease in literature.
SMVT deficiency is a vitamin-responsive inborn error of metabolism that can lead to a wide range of symptoms. Increased and isolated excretion of urinary 3-hydroxyisovaleric acid may suggest, in the absence of markedly reduced biotinidase activity, a SMVT deficiency. Prompt supplementation with high doses of biotin and pantothenic acid should be initiated while awaiting results of SLC5A6 sequencing as this condition may be life-threatening.
最近有研究报道,SLC5A6 中的双等位致病性变异导致钠依赖性多种维生素转运体(SMVT)缺陷,这种疾病类似于生物素酶缺乏症的维生素反应性先天性代谢缺陷。据我们所知,目前为止仅报道了 16 例具有不同临床表现的患者,包括神经病变和其他神经损伤、胃肠功能障碍和生长不良、骨质疏松症、免疫缺陷、代谢性酸中毒、低血糖症,以及最近出现严重的心脏症状。
我们描述了一例 5 月龄女婴的病例报告,该患儿在感染性疾病过程中出现了两次代谢性失代偿和严重心力衰竭反复发作。我们将该患者的临床、生物学和遗传学发现与从 Pubmed 数据库中收集的既往文献(关键词:钠依赖性多种维生素转运体(SMVT)、SMVT 缺陷/障碍/缺乏、SLC5A6 基因/突变)进行了比较。
我们强调了这种疾病的致命表现、精神运动发育停滞、严重和持续的低丙种球蛋白血症,以及早期维生素补充治疗(每天 15mg 生物素和 100mg 泛酸)的成功临床反应。代谢评估显示,尿液中 3-羟基异戊酸(3-HIA)持续增加,这与文献中该疾病的报道一致。
SMVT 缺陷是一种维生素反应性先天性代谢缺陷,可导致多种症状。在生物素酶活性明显降低的情况下,尿液中 3-羟基异戊酸的增加和孤立性排泄可能提示存在 SMVT 缺陷。应立即开始补充高剂量的生物素和泛酸,同时等待 SLC5A6 测序结果,因为这种情况可能危及生命。